Cancer immunotherapy, which uses drugs that stimulate the body's immune cells to attack tumors, is a promising approach to ...
Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and ...
New radioimmunotherapy approach eliminates cancer stem cells in preclinical models of ovarian cancer
A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the current gold standard. This research, ...
Chimeric antigen receptor (CAR) T cell therapy, which uses a patient's own immune cells to fight cancer, has emerged as a powerful way to treat lymphoma and other blood cancers. But researchers have ...
Prior research on the potential role of cytokines found that IL-6 signaling can reprogram and alter T-cell immune responses ...
Researchers combined protein biomarkers, cfDNA analysis, and machine learning to open opportunities for early-stage ovarian cancer screening and diagnostics. The cfDNA fragmentome is a genome-wide ...
“Our goal is really to get out all the cancer,” says Dr. Arvind Bakhru. In the operating room, the gynecologic oncologist relies on sight and feel to help identify the cancerous lesions he’ll remove.
Sept 29 (Reuters) - AbbVie (ABBV.N), opens new tab said on Monday it would launch its ovarian cancer drug Elahere in the UK at a list price matching that in the U.S. President Donald Trump has been ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback